November 24, 2012 in The Daily Republic
Dozens of lots feared to contain tiny glass particles.
December 19, 2011 in Grand Forks Herald
That’s despite a very aggressive effort by Lipitor maker Pfizer Inc. to keep patients on its pill, which generated peak sales of $13 billion a year, through patient subsidies and big rebates to insurers. Lipitor lost patent protection on Nov. 30 in the U.S. Continue Reading